Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip - Reuters https://t.co/5PaghSd1HW
— IDRO (@IDROOhio) April 30, 2019
from Twitter https://twitter.com/IDROOhio
April 30, 2019 at 07:24AM
Tuesday, April 30, 2019
Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip - Reuters https://t.co/5PaghSd1HW
from Twitter https://twitter.com/IDROOhio
April 30, 2019 at 07:24AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment